New Key Statistics Module, Z-Score and F-Score
SZSE:002589 Key Ratios
| Market Cap ¥ M | 3,325.41 |
| Enterprise Value ¥ M | 4,403.12 |
| P/E(ttm) | 245.56 |
| PE Ratio without NRI | 105.24 |
| Forward PE Ratio | -- |
| Price/Book | 0.61 |
| Price/Sales | 0.42 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) ¥ M | 7,980.00 |
| EPS (TTM) ¥ | 0.009 |
| Beneish M-Score | -2.24 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | 42.07 |
| EV-to-EBITDA | 42.07 |
| PEG | -- |
| Shares Outstanding M | 1,504.71 |
| Net Margin (%) | 0.18 |
| Operating Margin % | -1.58 |
| Pre-tax Margin (%) | -1.80 |
| Quick Ratio | 0.99 |
| Current Ratio | 1.09 |
| ROA % (ttm) | 0.08 |
| ROE % (ttm) | 0.26 |
| ROIC % (ttm) | 0.18 |
| Dividend Yield % | 0.59 |
| Altman Z-Score | 0.84 |
SZSE:002589 Number of Guru Trades
SZSE:002589 Volume of Guru Trades
Gurus Latest Trades with SZSE:002589
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:002589 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Realcan Pharmaceutical Group Co Ltd Insider Transactions
No Available Data
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers